The potential of 5‐methoxy‐N,N‐dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action

Documents similaires

• 5‐Methoxy‐ N , N ‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial
  par: John Marsden, et autres
  Publié: (2025)
• The potential mechanisms underlying the effect of acute alcohol use on duration perception
  par: Yunpeng Liu, et autres
  Publié: (2024)
• Neural responses to stress and alcohol cues in individuals with pain with and without alcohol use disorder
  par: Milena Radoman, et autres
  Publié: (2024)
• N‐acetylcysteine as a treatment for substance use cravings: A meta‐analysis
  par: Emma L. Winterlind, et autres
  Publié: (2024)
• Intra‐striatal dopaminergic inter‐subject covariance in social drinkers and non‐treatment‐seeking alcohol use disorder participants
  par: Evgeny J. Chumin, et autres
  Publié: (2024)